Protego Biopharma is gearing up to bring its amyloid light-chain (AL) amyloidosis prospect into pivotal testing using its new ...

Lecanemab, sold under the name Leqembi, is a monoclonal antibody therapy for Alzheimer's disease that clears toxic amyloid ...

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the progressive degradation of brain cells, as well ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

New findings show that removing Centaurin-α1, a protein elevated in Alzheimer’s disease, significantly reduces inflammation, plaque buildup, and cognitive deficits in a well-established mouse model.

"Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Market"Key Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Companies, including Pfizer, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Intellia ...

A Korean research team has identified the most effective OLED color capable of enhancing cognitive function in Alzheimer's ...

Researchers at Baylor College of Medicine have discovered a natural mechanism that clears existing amyloid plaques in the ...

Five years on from being the first person in the world to receive intravenous CRISPR treatment, Westmeath woman describes the clinical trial she participated in as ‘life-changing’ ...

The study evaluates the long-term cognitive abilities in the mice with over expression of Sox9 or elimination of the gene.

Transthyretin amyloid cardiomyopathy (ATTR-CM) is diagnosed using cardiac testing, heart imaging, genetic testing, and biopsies.